Grant: Doctoral Research Award: Canada Graduate Scholarships
McGill University
$105,000.00
Diet and obesity influence immune checkpoint inhibitor efficacy in lung cancer
FY 2021-22
Summary
Immune checkpoint inhibitors are a type of cancer therapy that targets your immune system's natural ability to fight cancer. This treatment has been revolutionary for lung cancer, which is often diagnosed late and is very deadly. However, only a minority of patients respond to immune checkpoint inhibitors so there is a need to identify why some patients benefit and others are resistant. Recent studies have shown that patients with a high body mass index (BMI) show improved survival following treatment with checkpoint inhibitors, compared to patients who are lean. One hallmark of obesity is disturbances in the composition of the gut microbiome - the bacteria and other organisms that live in your intestines. Interestingly, the gut microbiome greatly impacts patient response to checkpoint inhibitors. I am studying the link between obesity, the gut microbiome, and obesity-associated inflammation through their common link: diet. Changing your diet is a rapid, cost-effective, and accessible way to change the composition of your gut microbiome and the functioning of your immune system. This is an immuno-nutritional approach that will maximize the number and diversity of patients who will benefit from immune checkpoint inhibitors.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
458818
Name
Desharnais Lysanne
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Diet and obesity influence immune checkpoint inhibitor efficacy in lung cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Diet; Gut Microbiome; Immune Checkpoint Inhibitor; Inflammation; Obesity; Oncology
Abstract
Immune checkpoint inhibitors are a type of cancer therapy that targets your immune system's natural ability to fight cancer. This treatment has been revolutionary for lung cancer, which is often diagnosed late and is very deadly. However, only a minority of patients respond to immune checkpoint inhibitors so there is a need to identify why some patients benefit and others are resistant. Recent studies have shown that patients with a high body mass index (BMI) show improved survival following treatment with checkpoint inhibitors, compared to patients who are lean. One hallmark of obesity is disturbances in the composition of the gut microbiome - the bacteria and other organisms that live in your intestines. Interestingly, the gut microbiome greatly impacts patient response to checkpoint inhibitors. I am studying the link between obesity, the gut microbiome, and obesity-associated inflammation through their common link: diet. Changing your diet is a rapid, cost-effective, and accessible way to change the composition of your gut microbiome and the functioning of your immune system. This is an immuno-nutritional approach that will maximize the number and diversity of patients who will benefit from immune checkpoint inhibitors.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Desharnais, Lysanne
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~